Axillary reverse mapping (ARM): Initial results of phase II trial in preventing lymphedema after lymphadenectomy

Minerva Ginecologica

Volumn 64, Issue 5, 2012, Pages 421-430

  Boneti, C ^a   Badgwell, B ^a   Robertson, Y ^a   Korourian, S ^a   Adkins, L ^a   Klimberg, V ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Axilla, surgery; Breast neoplasms; Lymphedema

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; AXILLARY REVERSE MAPPING; FEMALE; FOLLOW UP; GENETIC VARIABILITY; HUMAN; LYMPH NODE DISSECTION; LYMPHATIC DRAINAGE; LYMPHEDEMA; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RECURRENT DISEASE; SENTINEL LYMPH NODE;

AXILLA; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHEDEMA; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84869209006     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Schijven MP, Vingerhoets AJ, Rutten HJ, Nieuwenhuijzen GA, Roumen RM, van Bussel ME, Voogd AC. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003;29:341-50. (Pubitemid 36675690)
2. Rönkä R, von Smitten K, Tasmuth T, Leidenius M. One-year morbidity after sentinel node biopsy and breast surgery. Breast 2005;14:28-36. (Pubitemid 40197824)
3. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000;88:608-14. (Pubitemid 30056936)
4. Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 2002;73:31-6. (Pubitemid 34548163)
5. Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 2002;9:745-53.
6. Blanchard DK, Donohue JH, Reynolds C, Díaz-Nieto R, Sánchez-Hidalgo JM, Luque A et al. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003;138:482-8. (Pubitemid 36542459)
7. Leidenius M, Leivonen M, Vironen J, von Smitten K. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol 2005;92:23-31. (Pubitemid 41416425)
8. Mansel R, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 2006;98:599-609. (Pubitemid 43904843)
9. Gill G: Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): A randomized controlled surgical trial. Ann Surg Oncol 2009;16:266-75.
10. Del Bianco P, Zavagno G, Burelli P, Burelli P, Scalco G, Barutta L, Carraro P et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: Results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 2008;34:508-13. (Pubitemid 351514885)
11. Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 2006;95:279-93.
12. Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: Results from a randomized controlled trial. J Clin Oncol 2005;23:4312-21. (Pubitemid 46209968)
13. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-53. (Pubitemid 36951366)
14. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011;305:569-75.
15. Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006;13.491-500.
16. Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM et al.; National Surgical Adjuvant Breast, Bowel Project. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 2010;102:111-8.
17. Romrell LJ, Bland KI. Anatomy of the breast, axilla, chest wall, and related metastatic sites. In: Bland, Copeland, editors. The breast. 4th ed. Philadelphia, PA: Saunders & Elsevier; 2009.
18. Gray H. The lymphatic system. In: Clement CD, editor. Anatomy of the human body. 30th ed. Philadelphia, PA: Lea & Febiger; 1985.
19. Mornard P. Sur deux cas de tumeurs malignes des mammelles axillaires aberrantes. Bull Mem Soc Chir Paris 1929;21:487.
20. Skandalakis JE, Skandalakis LJ, Skandalakis PN. Anatomy of the lymphatics. Surg Oncol Clin N Am 2007;16:1-16.
21. Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Onc Feb 2007;14:84-5.
22. Klimberg VS. A new concept toward the prevention of lymphedema: axillary reverse mapping. J Surg Oncol 2007;14:1890-5. (Pubitemid 46870948)
23. Nos C, Lesieur B, Clough KB, Lecuru F. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Ann Surg Oncol 2007;14:2490-6. (Pubitemid 47389579)
24. Ponzone R, Mininanni P, Cassina E, Sismondi P. Axillary reverse mapping in breast cancer: can we spare what we find? Ann Surg Oncol 2008;15:390-1; author reply 392-3.
25. Boneti C, Korourian S, Bland K, Cox K, Adkins LL, Henry-Tillman RS et al. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg 2008;200:1038-42; discussion 1042-4.
26. Nos C, Kaufmann G, Clough KB, Collignon MA, Zerbib E, Cusumano P et al. Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol 2008;15:2550-5.
27. Casabona F, Bogliolo S, Ferrero S, Boccardo F, Campisi C. Axillary reverse mapping in breast cancer: a new microsurgical lymphatic-venous procedure in the prevention of arm lymphedema. Ann Surg Oncol 2008;15:3318-9.
28. Kang SH, Choi JE, Jeon YS. Preservation of lymphatic drainage from arm in breast cancer surgery: Is it safe? Cancer Research 2009;69(Suppl 2):201.
29. Casabona F, Bogliolo S, Valenzano Menada M, Sala P, Villa G, Ferrero S. Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients. Ann Surg Oncol 2009;16:2459-63.
30. Boneti C, Korourian S, Diaz Z, Santiago C, Mumford S, Adkins L et al. Scientific Impact Award: Axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy. Am J Surg 2009;198:482-7.
31. Ponzone R, Cont NT, Maggiorotto F, Cassina E, Mininanni P, Biglia N et al. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer. J Clin Oncol 2009;27:5547-51.
32. Noguchi M, Yokoi M, Nakano Y. Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer. J Surg Oncol 2010;101:217-21.
33. Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK et al. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer 2010;116:2543-8.
34. Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Onc 2007;14:1890-5. (Pubitemid 46870948)
35. Földi M, Földi E. Földi's Textbook of Lymphology: for Physicians and Lymphedema Therapists. 2nd ed. New York, NY: Mosby Elsevier; 2006.
36. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010;11:927-33.
37. Yuregir-Adana, Turkey. Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction. Breast 2006;15:414-24.
38. Lambert-Falls R, Modugno S. Toxicity of dose-dense docetaxel followed by doxorubicin with cyclophosphamide as adjuvant therapy for breast cancer in a phase II study. Clin Breast Cancer 2007;7:697-704. (Pubitemid 47344732)
39. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001;92:1368-77. (Pubitemid 32947819)
40. Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol 2009;27:390-7.
41. Boccardo F, Casabona F, De Cian F, Friedman D, Villa G, Bogliolo S et al. Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol 2009;16:703-8.